Correction to: Metabolomics profiles of patients with Wilson disease reveal a distinct metabolic signature

Gaurav V Sarode; Kyoungmi Kim; Dorothy A Kieffer; Noreene M Shibata; Tomas Litwin; Anna Czlonkowska; Valentina Medici

doi:10.1007/s11306-019-1623-1

Correction to: Metabolomics profiles of patients with Wilson disease reveal a distinct metabolic signature

Metabolomics. 2019 Dec 3;16(1):3. doi: 10.1007/s11306-019-1623-1.

Authors

Gaurav V Sarode¹, Kyoungmi Kim², Dorothy A Kieffer¹, Noreene M Shibata¹, Tomas Litwin³, Anna Czlonkowska³, Valentina Medici⁴

Affiliations

¹ Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of California Davis, 4150 V Street, Suite 3500, Sacramento, CA, 95817, USA.
² Division of Biostatistics, Department of Public Health Sciences, University of California Davis, Davis, CA, USA.
³ Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland.
⁴ Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of California Davis, 4150 V Street, Suite 3500, Sacramento, CA, 95817, USA. vmedici@ucdavis.edu.

PMID: 31797141
DOI: 10.1007/s11306-019-1623-1

Abstract

In the originally published version of this article, there was an error. The metabolomics platform used for the analysis is GC-TOF-MS, Gas Chromatography Time-of-Flight Mass Spectrometry and not Hydrophilic Interaction Liquid Chromatography-Quadrupole Time of Flight Mass Spectrometry as indicated in the original version.

Publication types

Published Erratum